Источники. 1. Hall MH. Haemorrhage. In: Lewis G, editor

1. Hall MH. Haemorrhage. In: Lewis G, editor. Why Mothers Die 2000–2002. The Sixth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. London: RCOG Press; 2004. p. 86–93.

2. Iyasu S, Saftlas AK, Rowley DL, Koonin LM, Lawson HW, Atrash HK. The epidemiology of placenta previa in the United States, 1979 through 1987. Am J Obstet Gynecol 1993;168:1424–9.

3. Rossiter CE. Maternal mortality. Br J Obstet Gynaecol 1985;92 Suppl 5:100–15.

4. McShane PM, Heyl PS, Epstein MF. Maternal and perinatal morbidity resulting from placenta previa. Obstet Gynecol 1985;65:176–82.

5. Sheiner E, Shoham-Vardi I, Hallak M, Hershkowitz R, Katz M, Mazor M. Placenta previa: obstetric risk factors and pregnancy outcome. J Matern Fetal Med 2001;10:414–9.

6. Groom KM, Paterson-Brown S. Placenta praevia and placenta praevia accreta: a review of aetiology, diagnosis and management. Fetal Mat Med Review 2001;12:41–66.

7. Gielchinsky Y, Rojansky N, Fasouliotis SJ, Ezra Y. Placenta accrete – summary of 10 years: a survey of 310 cases. Placenta 2002;23:210–4.

8. Ananth CV, Smulian JC, Vintzileos AM. The effect of placenta praevia on neonatal mortality: a population-based study in the United States, 1989 through 1997. Am J Obstet Gynecol 2003;188:1299–304.

9. Salihu HM, Li Q, Rouse DJ, Alexander GR. Placenta previa: neonatal death after live births in the United States. Am J Obstet Gynecol 2003;188:1305–9.

10. Confidential Enquiry into Maternal and Child Health. Saving Mothers’ Lives: Reviewing maternal deaths to make motherhood safer – 2003–2005. The Seventh Report of the Confidential Enquiries into Maternal Deaths in the UK. London: CEMACH; 2007.

11. Knight M; UKOSS. Peripartum hysterectomy in the UK: management and outcomes of the associated haemorrhage. BJOG 2007;114:1380–7.

12. Ananth CV, Smulian JC, Vintzileos AM. The association of placenta previa with history of cesarean delivery and abortion: a metaanalysis. Am J Obstet Gynecol 1997;177:1071–8.

13. Frederiksen MC, Glassenberg R, Stika CS. Placenta previa: a 22-year analysis. Am J Obstet Gynecol 1999;180:1432–7.

14. Gilliam M, Rosenberg D, Davis F. The likelihood of placenta previa with greater number of cesarean deliveries and higher parity. Obstet Gynecol 2002;99:976–80.

15. Lyndon-Rochell M, Holt VL, Easterling TR, Martin DP. First-birth cesarean and placental bruption or previa at second birth. Obstet Gynecol 2001;97:765–9.

16. Faiz AS, Ananth CV. Etiology and risk factors for placenta previa: an overview and meta-analysis of observational studies. J Matern Fetal Neonatal Med 2003;13:175–90.

17. Miller DA, Chollet JA, Goodwin TM. Clinical risk factors for placenta praevia–placenta accreta. Am J Obstet Gynecol 1997;177:210–4.

18. Clark SL, Koonings PP, Phelan JP. Placenta praevia/accreta and prior cesarean section. Obstet Gynecol 1985;66:89–92.

19. Zaki ZM, Bahar AM, Ali ME, Albar HA, Gerias MA. Risk factors and morbidity in patients with placenta previa accrete compared to placenta previa non-accreta. Acta Obstet Gynecol Scand 1998;77:391–4.

20. Usta IM, Hobeika EM, Musa AA, Gabriel GE, Nassar AH. Placenta previa–accreta: risk factors and complications. Am J Obstet Gynecol 2005;193:1045–9.

21. Silver RM, Landon MB, Rouse DJ, Leveno KJ, Spong CY, Thom EA, et al.; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol 2006;107:1226–32.

22. Yang Q, Wen SW, Oppenheimer L, Chen XK, Black D, Gao J, et al. Association of caesarean delivery for first birth with placenta praevia and placental abruption in second pregnancy. BJOG 2007;114:609–13.

23. Grobman WA, Gersnoviez R, Landon MB, Spong CY, Leveno KJ, Rouse DJ, et al.; National Institute for Child Health and Human Development Maternal-Fetal Medicine Units Network. Pregnancy outcomes for women with placenta previa in relation to the number of prior cesarean deliveries. Obstet Gynecol 2007;110:1249–55.

24. Knight M, Kurinczuk JJ, Spark P, Brocklehurst P; United Kingdom Obstetric Surveillance System Steering Committee. Cesarean delivery and peripartum hysterectomy. Obstet Gynecol 2008;111:97–105.

25. Fung TY, Lau TK. Poor perinatal outcome associated with vasa previa: is it preventable? A report of three cases and review of the literature. Ultrasound Obstet Gynecol 1998;12:430–3.

26. Evans GM. Vasa praevia. Br Med J 1952;2:1243.

27. Catanzarite V, Maida C, Thomas W, Mendoza A, Stanco L, Piacquadio KM. Prenatal sonographic diagnosis of vasa previa: ultrasound findings and obstetric outcome in ten cases. Ultrasound Obstet Gynecol 2001;18:109–15.

28. Oleyese KO, Turner M, Lees C, Campbell S. Vasa previa: an avoidable obstetric tragedy. Obstet Gynecol Surv 1999;54:138–45.

29. Stafford IP, Neumann DE, Jarrell H. Abnormal placental structure and vasa previa: confirmation of the relationship. J Ultrasound Med 2004;23:1521–2.

30. Smorgick N, Tovbin Y, Ushakov F, Vaknin Z, Barzilay B, Herman A, et al. Is neonatal risk from vasa previa preventable? The 20-year experience from a single medical center. J Clin Ultrasound 2010;38:118–22.

31. Derbala Y, Grochal F, Jeanty P. Vasa previa. J Prenat Med 2007;1:2–13.

32. Antoine C, Young BK, Silverman F, Greco MA, Alvarez SP. Sinusoidal fetal heart rate pattern with vasa praevia in twin pregnancy. J Reprod Med 1982;27:295–300.

33. Cordero DR, Helfgott AW, Landy HJ, Reik RF, Medina C, O’Sullivan MJ. A non-hemorrhagic manifestation of vasa previa: a clinicopathologic case report. Obstet Gynecol 1993;82:698–700.

34. Dougall A, Baird CH. Vasa praevia – report of three cases and review of the literature. Br J Obstet Gynaecol 1987;94:712–5.

35. Oyelese Y, Catanzarite V, Prefumo F, Lashley S, Schachter M, Tovbin Y, et al. Vasa previa: the impact of prenatal diagnosis on outcomes. Obstet Gynecol 2004;103:937–42.

36. Oyelese Y, Smulian JC. Placenta previa, placenta accreta, and vasa previa. Obstet Gynecol 2006;107:927–41.

37. Oleyese Y, Spong C, Fernandez MA, McLaren RA. Second trimester low-lying placenta and in-vitro fertilization? Exclude vasa previa. J Matern Fetal Med 2000;9:370–2.

38. Francois K, Mayer S, Harris C, Perlow JH. Association of vasa previa at delivery with a history of second-trimester placenta previa. J Reprod Med 2003;48:771–4.

39. Duenhoelter JH. Survival of twins after acute fetal hemorrhage from ruptured vasa previa. Obstet Gynecol 1989;73:866–7.

40. Schachter M, Tovbin Y, Arieli S, Friendler S, Ron-El R, Sherman D. In vitro fertilization is a risk factor for vasa previa. Fertil Steril 2002;78:642–3.

41. Baulies S, Maiz N, Muñoz A, Torrents M, Echevarría, Sierra B. Prenatal ultrasound diagnosis of vasa praevia and analysis of risk factors. Prenat Diagn 2007;27:595–9.

42. Englert Y, Imbert MC, Van Rosandael E, Belaisch J, Segal L, Feichtinger W, et al. Morphological anomalies in the placentae of IVF pregnancies: preliminary report of a multicentric study. Human Reprod 1987;2:155–7.

43. Jauniaux E, Englert Y, Vanesse M, Hiden M, Wilkin P. Pathologic features of placentas from singleton pregnancies obtained by in vitro fertilization and embryo transfer. Obstet Gynecol 1990;76:61–4.

44. Paterson-Brown S, Singh C. Developing a care bundle for the management of suspected placenta accreta. The Obstetrician & Gynaecologist 2010;12:21–7.

45. National Collaborating Centre for Womens and Childrens Health. Antenatal care: routine care for the healthy pregnant woman. Clinical Guideline. London: RCOG Press; 2003.

46. Smith RS, Lauria MR, Comstock CH, Treadwell MC, Kirk JS, Lee W, et al. Transvaginal ultrasonography for all placentas that appear to be low-lying or over the internal cervical os. Ultrasound Obstet Gynecol 1997;9:22–4.

47. Lauria MR, Smith RS, Treadwell MC, Comstock CH, Kirk JS, Lee W, et al. The use of second-trimester transvaginal sonography to predict placenta praevia. Ultrasound Obstet Gynecol 1996;8:337–40.

48. Oyelese KO, Holden D, Awadh A, Coates S, Campbell S. Placenta praevia: the case for transvaginal sonography. Contemp Rev Obstet Gynaecol 1999;11:257–61.

49. Leerentveld RA, Gilberts EC, Arnold MJ, Wladimiroff JW. Accuracy and safety of transvaginal sonographic placental localisation. Obstet Gynecol 1990;76:759–62.

50. Oppenheimer LW, Farine D, Ritchie JW, Lewinsky RM, Telford J, Fairbanks LA. What is a low-lying placenta? Am J Obstet Gynecol 1991;165:1036–8.

51. Sherman SJ, Carlson DE, Platt LD, Mediaris AL. Transvaginal ultrasound: does it help in the diagnosis of placenta previa? Ultrasound Obstet Gynecol 1992;2:256–60.

52. Becker RH, Vonk R, Mende BC, Ragosch V, Entezami M. The relevance of placental location at 20–23 gestational weeks for prediction of placenta previa at delivery: evaluation of 8650 cases. Ultrasound Obstet Gynecol 2001;17:496–501.

53. Dashe JS, McIntire DD, Ramus RM, Santos-Ramos R, Twickler DM. Persistence of placenta previa according to gestational age at ultrasound detection. Obstet Gynecol 2002;99:692–7.

54. Mustafá SA, Brizot ML, Carvalho MH, Watanabe L, Kahhale S, Zugaib M. Transvaginal ultrasonography in predicting placenta previa at delivery: a longitudinal study. Ultrasound Obstet Gynecol 2002;20:356–9.

55. Ghourab S, Al-Jabari A. Placental migration and mode of delivery in placenta previa: transvaginal sonographic assessment during the third trimester. Ann Saudi Med 2000;20:382–5.

56. Taipale P, Hiilesmaa V, Ylöstalo P. Transvaginal ultrasonography at 18–23 weeks in predicting placenta praevia at delivery. Ultrasound Obstet Gynecol 1998;12:422–5.

57. Oppenheimer L, Holmes P, Simpson N, Dabrowski A. Diagnosis of low-lying placenta: can migration in the third trimester predict outcome? Ultrasound Obstet Gynecol 2001;18:100–2.

58. Zlatnik MG, Cheng YW, Norton ME, Thiet M-P, Caughey AB. Placenta previa and the risk of preterm delivery. J Matern Fetal Neonatal Med 2007;20:719–23.

59. Love CD, Wallace EM. Pregnancies complicated by placenta praevia: what is appropriate management? Br J Obstet Gynaecol 1996;103:864–7.

60. Chou MM, Ho ES. Prenatal diagnosis of placenta previa accrete with power amplitude ultrasonic angiography. Am J Obstet Gynecol 1997;177:1523–5.

61. Comstock CH, Love JJ Jr, Bronsteen RA, Lee W, Vettraino IM, Huang RR, et al. Sonographic detection of placenta accreta in the second and third trimesters of pregnancy. Am J Obstet Gynecol 2004;190:1135–40.

62. Megier P, Harmas A, Mesnard L, Esperandieu OL, Desroches A. Picture of the month. Antenatal diagnosis of placenta percreta using gray-scale ultrasonography, color and pulsed Doppler imaging. Ultrasound Obstet Gynecol 2000;15:268.

63. Fisher SJ, Zhou Y, Huang L, Winn VD. When is seeing believing? The use of color Doppler ultrasound to diagnose placenta accreta in the first trimester of pregnancy. Ultrasound Obstet Gynecol 2002;19:540–2.

64. Chen YJ, Wang PH, Liu WM, Lai CR, Shu LP, Hung JH. Placenta accreta diagnosed at 9 weeks’ gestation. Ultrasound Obstet Gynecol 2002;19:620–2.

65. Chou MM, Ho ES, Lee YH. Prenatal diagnosis of placenta previa accreta by transabdominal color Doppler ultrasound. Ultrasound Obstet Gynecol 2000;15:28–35.

66. Chou MM, Tseng JJ, Ho ES, Hwang JI. Three-dimensional color power Doppler imaging in the assessment of uteroplacental neovascularization in placenta previa increta/percreta. Am J Obstet Gynecol 2001;185:1257–60.

67. Chou MM, Tseng JJ, Ho ES. The application of three-dimensional color power Doppler ultrasound in the depiction of abnormal uteroplacental angioarchitecture in placenta previa percreta. Ultrasound Obstet Gynecol 2002;19:625–7.

68. Wong HS, Cheung YK, Zuccollo J, Tait J, Pringle KC. Evaluation of sonographic diagnostic criteria for placenta accreta. J Clin Ultrasound 2008;36:551–9.

69. Shih JC, Palacios JM, Su YN, Shyu MK, Lin CH, Lin SY, et al. Role of three-dimensional power Doppler in the antenatal diagnosis of placenta accreta: comparison with gray-scale and color Doppler techniques. Ultrasound Obstet Gynecol 2009;33:193–203.

70. Dwyer BK, Belogolovkin V, Tran L, Rao A, Carroll I, Barth R, et al. Prenatal diagnosis of placenta accreta: sonography or magnetic resonance imaging? J Ultrasound Med 2008;27:1275–81.

71. Masselli G, Brunelli R, Casciani E, Polettini E, Piccioni MG, Anceschi M, et al. Magnetic resonance imaging in the evaluation of placental adhesive disorders: correlation with color Doppler ultrasound. Eur Radiol 2008;18:1292–9.

72. Palacios Jaraquemada JM, Bruno CH. Magnetic resonance imaging in 300 cases of placenta accreta: surgical correlation of new findings. Acta Obstet Gynecol Scand 2005;84:716–24.

73. Warshak CR, Eskander R, Hull AD, Scioscia AL, Mattrey RF, Benirschke K, et al. Accuracy of ultrasonography and magnetic resonance imaging in the diagnosis of placenta accreta. Obstet Gynecol 2006;108:573–81.

74. Lax A, Prince MR, Mennitt KW, Schwebach JR, Budorick NE. The value of specific MRI features in the evaluation of suspected placental invasion. Magn Reson Imaging 2007;25:87–93.

75. Neilson JP. Interventions for suspected placenta praevia. Cochrane Database Syst Rev 2000;(1):CD001998.

76. Wing DA, Paul RH, Millar LK. Management of the symptomatic placenta previa: a randomized, controlled trial of inpatient versus outpatient expectant management. Am J Obstet Gynecol 1996;175:806–11.

77. Love CD, Fernando KJ, Sargent L, Hughes RG. Major placenta praevia should not preclude out-patient management. Eur J Obstet Gynaecol Repr Biol 2004;117:24–9.

78. Ghi T, Contro E, Martina T, Piva M, Morandi R, Orsini LF, et al. Cervical length and risk of antepartum bleeding in women with complete placenta previa. Ultrasound Obstet Gynecol 2009;33:209–12.

79. Royal Australian and New Zealand College of Obstetricians and Gynaecologists. College Statement: C-Obs 20. Placenta Accreta. Melbourne, Australia: RANZCOG; 2003 [www.ranzcog.edu.au/publications/statements/C-obs20.pdf].

80. Arias F. Cervical cerclage for the temporary treatment of patients with placenta previa. Obstet Gynecol 1988;71:545–8.

81. Cobo E, Conde-Agudelo A, Delgado J, Canaval H, Congote A. Cervical cerclage: an alternative for the management of placenta praevia? Am J Obstet Gynecol 1998;179:122–5.

82. Cotton DB, Read JA, Paul RH, Quilligan EJ. The conservative aggressive management of placenta previa. Am J Obstet Gynecol 1980;137:687–95.

83. Silver R, Depp R, Sabbagha RE, Dooley SL, Socol ML, Tamura RK. Placenta previa: aggressive expectant management. Am J Obstet Gynecol 1984;150:15–22.

84. Sharma A, Suri V, Gupta I. Tocolytic therapy in conservative management of symptomatic placenta previa. Int J Gynaecol Obstet 2004:84:109–13.

85. Besinger RE, Moniak CW, Paskiewicz LS, Fisher SG, Tomich PG. The effect of tocolytic use in the management of symptomatic placenta previa. Am J Obstet Gynecol 1995;172:1770–8.

86. Towers CV, Pircon RA, Heppard M. Is tocolysis safe in the management of third-trimester bleeding? Am J Obstet Gynecol 1999;180:1572–8.

87. Magann EF, Johnson CA, Gookin KS, Roberts WE, Martin RW, Morrison JC. Placenta praevia: does uterine activity cause bleeding? Aust N Z J Obstet Gynaecol 1993;33:22–4.

88. Royal College of Obstetricians and Gynaecologists. Green-top Guideline No. 37: Reducing the risk of thrombosis and embolism during pregnancy and the puerperium. London: RCOG; 2009.[ http://www.rcog.org.uk/files/rcogcorp/ GT37ReducingRiskThrombo.pdf].

89. Bhide A, Prefumo F, Moore J, Hollis B, Thilaganathan B. Placenta edge to internal os distance in the late third trimester and mode of delivery in placenta praevia. BJOG 2003;110:860–4.

90. Ghourab S. Third-trimester transvaginal ultrasonography in placenta previa: does the shape of the lower placental edge predict clinical outcome? Ultrasound Obstet Gynecol 2001;18:103–8.

91. Morrison JJ, Rennie JM, Milton PJ. Neonatal respiratory morbidity and mode of delivery at term: influence of timing of elective caesarean section. Br J Obstet Gynaecol 1995;102:101–6.

92. Royal College of Obstetricians and Gynaecologists. Green–top Guideline No.7: Antenatal corticosteroids to reduce neonatal morbidity and mortality. London: RCOG; 2010 [http://www.rcog.org.uk/files/rcog-corp/GTG%207.pdf].

93. Royal College of Obstetricians and Gynaecologists (RCOG), Royal College of Midwives (RCM) and the National Patient Safety Agency (NPSA). Placenta praevia after caesarean section care bundle [http://www.nrls.npsa.nhs.uk/intrapartumtoolkit/? entryid45=66359].

94. Royal College of Obstetricians and Gynaecologists. Green-top Guideline No. 49: Blood transfusions in obstetrics. London: RCOG; 2008 [http://www.rcog.org.uk/files/rcog-corp/uploaded-files/GT47BloodTransfusions 1207 amended.pdf].

95. Dinsmoor MJ, Hogg BB. Autologous blood donation with placenta previa: is it feasible? Am J Perinatol 1995;12:382–4.

96. The Blood Safety and Quality Regulations 2005. Statutory Instrument 2005 No. 50. London: The Stationery Office; 2005 [http://www.opsi.gov.uk/SI/si2005/20050050.htm].

97. Catling SJ, Williams S, Fielding AM. Cell salvage in obstetrics: an evaluation of the ability of cell salvage combined with leucocyte depletion filtration to remove amniotic fluid from operative blood loss at caesarean section. Int J Obstet Anaesth 1999;8:79–84.

98. Waters JH, Biscotti C, Potter PS, Phillipson E. Amniotic fluid removal during cell salvage in the cesarean section patient. Anesthesiology 2000;92:1531–6.

99. Weiskopf RB. Erythrocyte salvage during cesarean section. Anesthesiology 2000;92:1519–22.

100. Catling S. Blood conservation techniques in obstetrics: a UK perspective. Int J Obstet Anesth 2007;16:241–9.

101. Allam J, Cox M, Yentis SM. Cell salvage in obstetrics. Int J Obstet Anesth 2008;17:37–45.

102. National Institute for Health and Clinical Excellence. Intraoperative blood cell salvage in obstetrics. Interventional Procedure Guidance No.144. London: NICE; 2005 [http://www.nice.org.uk/nicemedia/live/11038/30690/30690.pdf].

103. De Souza A, Permezel M, Anderson M, Ross A, McMillan J, Walker S. Antenatal erythropoietin and intra-operative cell salvage in a Jehovah’s witness with placenta praevia. BJOG 2003;110:524–6.

104. Committee on Obstetric Practice. ACOG committee opinion. Placenta accreta. Number 266, January 2002. American College of Obstetricians and Gynecologists. Int J Gynecol Obstet 2002;77:77–8.

105. The Association of Anaesthetists of Great Britain and Ireland Obstetric Anaesthetists’ Association. OAA/AAGBI Guidelines for Obstetric Anaesthetic Services Revised Edition 2005. London: OAA/AAGBI; 2005 [http://www.aagbi.org/publications/guidelines/docs/obstetric05.pdf].

106. Pelage JP, Le Dref O, Mateo J, Soyer P, Jacob D, Kardache M, et al. Life-threatening primary postpartum hemorrhage: treatment with emergency selective arterial embolization. Radiology 1998;208:359–62.

107. Hansch E, Chitkara U, McAlpine J, El-Sayed Y, Dake MD, Razavi MK. Pelvic arterial embolization for control of obstetric hemorrhage: a five year experience. Am J Obstet Gynecol 1999;180:1454–60.

108. Doumouchtsis SK, Papageorghiou AT, Aris T, Arulkumaran S. Systematic review of conservative management of postpartum haemorrhage: what to do when medical treatment fails. Obstet Gynecol Surv 2007;62:540–7.

109. Boulleret C, Chahid T, Gallot D, Mofid R, Tran Hai D, Ravel A, et al. Hypogastric arterial selective and superselective embolization for severe postpartum hemorrhage: a retrospective review of 36 cases. Cardiovasc Intervent Radiol 2004;27:344–8.

110. Uchiyama D, Koganemaru M, Abe T, Hori D, Hayabuchi N. Arterial catheterization and embolization for management of emergent or anticipated massive obstetrical hemorrhage. Radiat Med 2008;26:188–97.

111. Alvarez M, Lockwood CJ, Ghidini A, Dottino P, Mitty HA, Berkowitz RL. Prophylactic and emergent arterial catheterization for selective embolization in obstetric hemorrhage. Am J Perinatol 1992;9:441–4.

112. Mitty HA, Sterling KM, Alvarez M, Gendler R. Obstetric hemorrhage: prophylactic and emergency arterial catheterization and embolotherapy. Radiology 1993;188:183–7.

113. Dubois J, Garel L, Grignon A, Lemay M, Leduc L. Placenta percreta: balloon occlusion and embolization of the internal iliac arteries to reduce intraoperative blood losses. Am J Obstet Gynecol 1997;176:723–6.

114. Ojala K, Perälä J, Kariniemi J, Ranta P, Raudaskoski T, Tekay A. Arterial embolization and prophylactic catheterization for the treatment for severe obstetric hemorrhage. Acta Obstet Gynecol Scand 2005;84:1075–80.

115. Levine AB, Kuhlman K, Bonn J. Placenta accreta: comparison of cases managed with and without pelvic artery balloon catheters. J Matern Fetal Med 1999;8:173–6.

116. Bodner LJ, Nosher JL, Gribbin C, Siegel RL, Beale S, Scorza W. Balloon-assisted occlusion of the internal iliac arteries in patients with placenta accreta/percreta. Cardiovasc Intervent Radiol 2006;29:354–61.

117. Shrivastava V, Nageotte M, Major C, Haydon M, Wing D. Casecontrol comparison of cesarean hysterectomy with and without prophylactic placement of intravascular balloon catheters for placenta accreta. Am J Obstet Gynecol 2007;197:402.e1–5.

118. Tan CH, Tay KH, Sheah K, Kwek K, Wong K, Tan HK, et al. Perioperative endovascular internal iliac artery occlusion balloon placement in management of placenta accreta. Am J Radiol 2007;189:1158–63.

119. Mok M, Heidemann B, Dundas K, Gillespie I, Clark V. Interventional radiology in women with suspected placenta accreta undergoing caesarean section. Int J Obstet Anesth 2008;17:255–61.

120. Sewell MF, Rosenblum D, Ehrenberg H. Arterial embolus during common iliac balloon catheterization at cesarean hysterectomy. Obstet Gynecol 2006;108:746–8.

121. Royal College of Obstetricians and Gynaecologists. Green–top Guideline No.52: Prevention and management of postpartum haemorrhage. London: RCOG; 2009.

122 Bonner SM, Haynes SR, Ryall D. The anaesthetic management of Caesarean section for placenta praevia: a questionnaire survey. Anaesthesia 1995;50:992–4.

123. Parekh N, Husaini SW, Russell IF. Caesarean section for placenta praevia: a retrospective study of anaesthetic management. Br J Anaesth 2000;84:725–30.

124. Hong JY, Jee YS, Yoon HJ, Kim SM. Comparison of general and epidural anesthesia in elective cesarean section for placenta previa totalis: maternal hemodynamics, blood loss and neonatal outcome. Int J Obstet Anaesth 2003:12:12–6.

125. Royal College of Obstetricians and Gynaecologists. Consent Advice No. 7: Caesarean section. London: RCOG; 2009.

126. Brace V, Kernaghan D, Penney G. Learning from adverse clinical outcomes: major obstetric haemorrhage in Scotland, 2003–05. BJOG 2007;114:1388–96.

127. Silver RM, Landon MB, Rouse DJ, Leveno KJ, Spong CY, Thom EA, et al.; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol 2006;107:1226–32.

128. Wong HS, Hutton J, Zuccollo J, Tait J, Pringle KC. The maternal outcome in placenta accreta: the significance of antenatal diagnosis and non-separation of placenta at delivery. N Z Med J 2008;121:30–8.

129. Eller AG, Porter TF, Soisson P, Silver RM. Optimal management strategies for placenta accreta. BJOG 2009;116:648–54.

130. Timmermans S, van Hof AC, Duvekot JJ. Conservative management of abnormally invasive placentation. Obstet Gynecol Surv 2007;62:529–39.

131. Bretelle F, Courbière B, Mazouni C, Agostini A, Cravello L, Boubli L, et al. Management of placenta accreta: morbidity and outcome. Eur J Obstet Gynecol Repro Biol 2007;133:34–9.

132. Chan BC, Lam HS, Yuen JH, Lam TP, Tso WK, Pun TC, et al. Conservative management of placenta praevia with accreta. Hong Kong Med J 2008;14:479–84.

133. Lee PS, Bakelaar R, Fitpatrick CB, Ellestad SC, Havrilesky LJ, Alvarez Secord A. Medical and surgical treatment of placenta percreta to optimize bladder preservation. Obstet Gynecol 2008;112:421–4.

134. Most OL, Singer T, Buterman I, Monteagudo A, Timor-Tritsch IE. Postpartum management of placenta previa accreta left in situ: role of 3-dimensional angiography. J Ultrasound Med 2008;27:1375–80.

135. Teo SB, Kanagalingam D, Tan HK, Tan LK. Massive postpartum haemorrhage after uterus-conserving surgery in placenta percreta: the danger of the partial placenta percreta. BJOG 2008;115:789–92.

136. Chiang YC, Shih JC, Lee CN. Septic shock after conservative management for placenta accreta. Taiwan J Obstet Gynecol 2006;45:64–6.

137. Oleen MA, Mariano JP. Controlling refractory atonic postpartum haemorrhage with Hemabate sterile solution. Am J Obstet Gynecol 1990;162:205–8.

138. Al-Harbi NA, Al-Abra ES, Alabbad NS. Utero-vaginal packing. Seven years review in the management of post partum hemorrhage due to placenta previa/accreta at a maternity hospital in Central Saudi Arabia. Saudi Med J 2009;30:243–6.

139. Ferrazzani S, Guariglia L, Triunfo S, Caforio L, Caruso A. Successful treatment of post-cesarean hemorrhage related to placenta praevia using an intrauterine balloon. Two case reports. Fetal Diagn Ther 2006;21:277–80.

140. Frenzel D, Condous GS, Papageorghiou AT, McWhinney NA. The use of the “tamponade test” to stop massive obstetric haemorrhage in placenta accreta. BJOG 2005;112:676–7.

141. B-Lynch C, Coker A, Lawal AH, Abu I, Cowen MJ. The B-Lynch surgical technique for the control of massive postpartum haemorrhage: an alternative to hysterectomy? Five cases reported. Br J Obstet Gynaecol 1997;104:372–5.

142. Hwu YM, Chen CP, Chen HS, Su TH. Parallel vertical compression sutures: a technique to control bleeding from placenta praevia or accreta during caesarean section. BJOG 2005;112:1420–3.

143. Dawlatly B, Wong I, Khan K, Agnihotri S. Using the cervix to stop bleeding in a woman with placenta accreta: a case report. BJOG 2007;114:502–4.

144. O’Leary JA. Uterine artery ligation in the control of postcesarean hemorrhage. J Reprod Med 1995;40:189–93.

145. Clark SL, Phelan JP, Yeh SY, Bruce SR, Paul RH. Hypogastric artery ligation for obstetric hemorrhage. Obstet Gynecol 1985;66:353–6.

146. Kayem G, Clément D, Goffinet F. Recurrence following conservative management of placenta accreta. Int J Gynaecol Obstet 2007;99:142–3.

147. Young M, Yule N, Barham K. The role of light and sound technologies in the detection of vasa praevia. Reprod Fertil Dev 1991;3:439–45.

148. Kleihauer E, Braun H, Bethe K. [Demonstration of fetal hemoglobin in erythrocytes of a blood smear]. KlinWochenschr 1957;35:637–8. Article in German.

149. Apt L, Downey Jr WS. Melena neonatorum: the swallowed blood syndrome; a simple test for the differentiation of adult and fetal hemoglobin in bloody stools. J Paediatr 1955;47:6–12.

150. Ogita S, Ishiko O, Matsumoto M, Hasegawa H, Sugawa T. A simplified method for measuring fetal hemoglobin. Obstet Gynecol 1976;48:237–8.

151. Loendersloot EW. Vasa previa. Am J Obstet Gynecol 1979;135:702–3.

152. Jones KP, Wheater AW, Musgrave W. Simple test for bleeding from vasa praevia. Lancet 1987;2:1430–1.

153. Lindqvist PG, Gren P. An easy-to-use method for detecting fetal hemoglobin – a test to identify bleeding from vasa previa. Eur J Obstet Gynecol Reprod Biol 2007;131:151–3.

154. Gianopoulos J, Carver T, Tomich PG, Karlman R, Gadwood K. Diagnosis of vasa previa with ultrasonography. Obstet Gynecol 1987;69:488–91.

155. Lee W, Lee VL, Kirk JS, Sloan CT, Smith RS, Comstock CH. Vasa previa: prenatal diagnosis, natural evolution, and clinical outcome. Obstet Gynecol 2000;95:572–6.

156. Nelson LH, Melone PJ, King M. Diagnosis of vasa previa with transvaginal and color flow Doppler ultrasound. Obstet Gynecol 1990;76:506–9.

157. Baschat AA, Gembruch U. Ante- and intrapartum diagnosis of vasa praevia in singleton pregnancies by colour coded Doppler sonography. Eur J Obstet Gynecol Reprod Biol 1998;79:19–25.

158. Sepulveda W, Rojas I, Robert JA, Schnapp C, Alcalde JL. Prenatal detection of velamentous insertion of the umbilical cord: a prospective color Doppler ultrasound study. Ultrasound Obstet Gynecol 2003;21:564–9.

159. Daly-Jones E, John A, Leahy A, Mckenna C, Sepulveda W. Vasa praevia; a preventable tragedy. Ultrasound 2008;16:8–14.

160. Benirschke K, Kaufmann P. Pathology of the human placenta. 4th ed. New York: Springer-Verlag; 2000. p. 353–9, p. 401–5.

161. Quek SP, Tan KL. Vasa praevia. Aust N Z J Obstet Gynaecol 1972;12:206–9.

162. Paavonen J, Jouttunnpää K, Kangasluoma P, Aro P, Heinonen PK. Velamentous insertion of the umbilical cord and vasa previa. Int J Obstet Gynecol 1984;22:207–11.

163. Nomiyama M, Toyota Y, Kawano H. Antenatal diagnosis of velamentous umbilical cord insertion and vasa previa with color Doppler imaging. Ultrasound Obstet Gynecol 1998;12:426–9.

164. Diagnostic Imaging Committee and Maternal Fetal Medicine Committee, Society of Obstetricians and Gynaecologists of Canada. SOGC Clinical Practice Guideline. Guidelines for the management of vasa previa. J Obstet Gynaecol Can 2009;231:748–53.[http://www.sogc.org/guidelines/documents/ gui231 CPG0908. pdf].

165. UK National Screening Committee. The UK NSC policy on Placenta praevia screening in pregnancy [http://www.screening.nhs.uk/placentapraevia]. Accessed August 2010.

166. Al-Khaduri M, Kadoch IJ, Couturier B, Dubé J, Lapensée L, Bissonnette F. Vasa praevia after IVF: should there be guidelines? Report of two cases and literature review. Reprod Biomed Online 2007;14:372–4.

167. National Institute for Health and Clinical Excellence. NICE clinical guideline 55: Intrapartum care: Care of healthy women and their babies during childbirth. London: NICE; 2007.

168. National Institute for Clinical Excellence. Clinical Guideline 13: Caesarean section. London: National Institute for Clinical Excellence; 2004 [http://www.gserve.nice.org.uk/nicemedia/pdf/CG013NICEguideline.pdf].

169. Quintero RA, Kontopoulos EV, Bornick PW, Allen MH. In utero laser treatment of type II vasa previa. J Matern Fetal Neonatal Med 2007;20:847–51.